Capricor Therapeutics (CAPR) Q1 2026 Earnings

12MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.62
-0.52
-0.42
-0.32

Details

Expected EPS
-0.509
Actual EPS
-0.62
Surprise EPS
-0.11
Surprise Percent
+21.81%

Description

Capricor Therapeutics (CAPR) has reported earnings of -0.62 per share for Q1 2026.

0 Comments

Share your thoughts